pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Will AI like Claude ever earn a Nobel Prize in medicine?

Oct 5, 2026·read at STAT ↗Neutral

Jeffrey S. Flier, a distinguished professor at Harvard and former dean of Harvard Medical School, writes an opinion piece prompted by the recent Nobel announcement. He asks whether an artificial-intelligence system such as Claude or future AI models could ever be awarded the Nobel Prize for medicine.

Flier imagines a scenario where an AI, responding to a scientist’s prompt, discovers a completely new approach to curing cancer and provides a detailed implementation plan. He notes that, historically, human researchers have received credit and awards for such breakthroughs, and he wonders how credit would be assigned in a world where AI contributes the key insight.

The author concludes by urging the scientific community to discuss how innovation, credit, and recognition should evolve as AI becomes more capable, questioning whether awarding a Nobel to an AI would change the meaning of the prize.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Will Claude ever win a Nobel Prize for medicine?”

read at STAT ↗
1,267 words · retrieved 55m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Oncology5GLP-1 receptorRare Disease

related stories

  • 6h agoSwiss CDMOs and CROs ride a new wave of growth amid surge in global demandBioSpace
  • 4d agoOpinion: Claude analyzed my genome in 30 minutes. Now we need standards for the resultsSTAT
  • 5d agoSTAT+: AstraZeneca invests $2 billion in Summit TherapeuticsSTAT
  • Sep 23Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitzBioSpace
  • Sep 4This week in charts: China deals, stock flatlines and Lilly’s M&A spreeBioPharma Dive